Publications

Rich, J. N., M. L. Affronti, J. M. Day, J. E. Herndon, J. A. Quinn, D. A. Reardon, J. J. Vredenburgh, A. Desjardins, and H. S. Friedman. “Overall survival of primary glioblastoma (GBM) patients (pts) receiving carmustine (BCNU) wafers followed by radiation (RT) and concurrent temozolomide (TMZ) plus rotational multi-agent.” In Journal of Clinical Oncology, Vol. 25. AMER SOC CLINICAL ONCOLOGY, 2007.

Scholars@Duke

Desjardins, A., D. P. Barboriak, J. E. Herndon, D. A. Reardon, J. A. Quinn, J. N. Rich, S. Sathornsumetee, S. Gururangan, H. S. Friedman, and J. J. Vredenburgh. “Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) evaluation in glioblastoma (GBM) patients treated with bevacizumab (BEV) and irinotecan (CPT-11).” In Journal of Clinical Oncology, Vol. 25. AMER SOC CLINICAL ONCOLOGY, 2007.

Scholars@Duke

Riedel, R. F., A. Porrello, E. Chenette, A. Potti, J. R. Nevins, and P. G. Febbo. “A genomic approach to identify mechanisms associated with chemotherapy resistance.” In Journal of Clinical Oncology, Vol. 25. AMER SOC CLINICAL ONCOLOGY, 2007.

Scholars@Duke

Vlahovic, G., T. L. Foster, C. H. Andrews, J. E. Herndon, T. Sporn, M. J. Kelley, M. W. Dewhirst, and Z. Vujaskovic. “Phase I dose escalation, toxicity and dynamic contrast-enhanced (DCE) MRI imaging biomarker study of first line treatment with imatinib (I) and cisplatin (C) plus docetaxel (D) in patients with advanced non-small cell lung cancer (NSCLC).” In Journal of Clinical Oncology, Vol. 25. AMER SOC CLINICAL ONCOLOGY, 2007.

Scholars@Duke

Quinn, J. A., J. J. Vredenburgh, J. N. Rich, D. A. Reardon, A. Desjardins, S. Gururangan, A. H. Friedman, J. H. Carter, S. Threatt, and H. S. Friedman. “Phase II trial of Gliadel plus O-6-benzylguanic (O-6-BG) for patients with recurrent glioblastoma multiforme.” In Journal of Clinical Oncology, Vol. 25. AMER SOC CLINICAL ONCOLOGY, 2007.

Scholars@Duke

Hassan, Manal M., James L. Abbruzzese, Melissa L. Bondy, Robert A. Wolff, Jean-Nicolas Vauthey, Peter W. Pisters, Douglas B. Evans, et al. “Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study..” Cancer 109, no. 12 (June 15, 2007): 2547–56. https://doi.org/10.1002/cncr.22724.

PMID
17492688
Full Text

Li, Donghui, Li-E Wang, Ping Chang, Adel K. El-Naggar, Erich M. Sturgis, and Qingyi Wei. “In vitro benzo[a]pyrene diol epoxide-induced DNA adducts and risk of squamous cell carcinoma of head and neck..” Cancer Res 67, no. 12 (June 15, 2007): 5628–34. https://doi.org/10.1158/0008-5472.CAN-07-0983.

PMID
17575128
Full Text

Spector, Neil L., Yosef Yarden, Bradley Smith, Ljuba Lyass, Patricia Trusk, Karen Pry, Jason E. Hill, Wenle Xia, Rony Seger, and Sarah S. Bacus. “Activation of AMP-activated protein kinase by human EGF receptor 2/EGF receptor tyrosine kinase inhibitor protects cardiac cells..” Proceedings of the National Academy of Sciences of the United States of America 104, no. 25 (June 7, 2007): 10607–12. https://doi.org/10.1073/pnas.0701286104.

PMID
17556544
Full Text

Riedel, Richard F., Carolyn Andrews, Jennifer Garst, Frank Dunphy, James E. Herndon, Susan Blackwell, Sally Barbour, and Jeffrey Crawford. “A phase II trial of carboplatin/vinorelbine with pegfilgrastim support for the treatment of patients with advanced non-small cell lung cancer..” J Thorac Oncol 2, no. 6 (June 2007): 520–25. https://doi.org/10.1097/JTO.0b013e318060107c.

PMID
17545847
Full Text

Czito, Brian G., Johanna C. Bendell, Christopher G. Willett, Michael A. Morse, Gerard C. Blobe, Douglas S. Tyler, John Thomas, et al. “Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results..” Int J Radiat Oncol Biol Phys 68, no. 2 (June 1, 2007): 472–78. https://doi.org/10.1016/j.ijrobp.2007.02.001.

PMID
17498568
Full Text

Pages